Pharmafile Logo

Glaucoma in perspective

- PMLiVE

Shining a Spotlight on Patient Centricity in Frankfurt for EHA

The Medscape Oncology team has made their way back from Frankfurt, Germany after another successful EHA 2023 conference. While at the event, the team interacted with conference attendees at the...

Medscape Education

- PMLiVE

AbbVie files patent infringement lawsuit against BeiGene’s blood cancer drug Brukinsa

The BTK inhibitor was approved in the US earlier this year and had its patent issued last week

- PMLiVE

Merck reports positive phase 3 results for Keytruda combination in gastric cancer

Over one million new cases of gastric cancer were diagnosed globally in 2020

- PMLiVE

Skylines and Oncology Headlines in Chicago for ASCO 2023

ASCO 2023 was a huge success for Medscape Oncology with connections made with members and conference attendees during the event at the Medscape Oncology booth on the exhibit floor and...

Medscape Education

- PMLiVE

Roche’s fixed-duration lymphoma treatment granted FDA accelerated approval

Globally around 160,000 people are diagnosed with non-Hodgkin's lymphoma each year

- PMLiVE

FDA advisory committee backs updated COVID-19 vaccines targeting XBB variants

The XBB.1.5 variant accounted for nearly 40% of all US COVID-19 cases as of early June

- PMLiVE

Powering creativity to work in harmony with science and data

Companies need creativity at the heart of their output – with social media and new channels presenting new horizons and challenges

- PMLiVE

Genetically altered vaccines developed to help eradicate polio

The vaccines have been prevented from mutating into a dangerous form that can cause outbreaks

- PMLiVE

AbbVie announces positive phase 3 results for Skyrizi in ulcerative colitis

Inflammatory bowel disease is estimated to affect nearly one in every 100 people in the US

- PMLiVE

Lilly announces two new senior leadership hires

Rachel Batterham and Emily Pegg join as senior VP and associate VP respectively

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links